Literature DB >> 15894650

Analyzing patterns of staining in immunohistochemical studies: application to a study of prostate cancer recurrence.

Ruth Etzioni1, Sarah Hawley, Dean Billheimer, Lawrence D True, Beatrice Knudsen.   

Abstract

BACKGROUND: Immunohistochemical studies use antibodies to stain tissues with the goal of quantifying protein expression. However, protein expression is often heterogeneous resulting in variable degrees and patterns of staining. This problem is particularly acute in prostate cancer, where tumors are infiltrative and heterogeneous in nature. In this article, we introduce analytic approaches that explicitly consider both the frequency and intensity of tissue staining.
METHODS: Compositional data analysis is a technique used to analyze vectors of unit-sum proportions, such as those obtained from soil sample studies or species abundance surveys. We summarized specimen staining patterns by the proportion of cells staining at mild, moderate, and intense levels and used compositional data analysis to summarize and compare the resulting staining profiles.
RESULTS: In a study of Syndecan-1 staining patterns among 44 localized prostate cancer cases with Gleason score 7 disease, compositional data analysis did not detect a statistically significant difference between the staining patterns in recurrent (n = 22) versus nonrecurrent (n = 22) patients. Results indicated only modest increases in the proportion of cells staining at a moderate intensity in the recurrent group. In contrast, an analysis that compared quantitative scores across groups indicated a (borderline) significant increase in staining in the recurrent group (P = 0.05, t test).
CONCLUSIONS: Compositional data analysis offers a novel analytic approach for immunohistochemical studies, providing greater insight into differences in staining patterns between groups, but possibly lower statistical power than existing, score-based methods. When appropriate, we recommend conducting a compositional data analysis in addition to a standard score-based analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894650     DOI: 10.1158/1055-9965.EPI-04-0584

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

Review 1.  Methodological requirements for valid tissue-based biomarker studies that can be used in clinical practice.

Authors:  Lawrence D True
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

2.  Robust unmixing of tumor states in array comparative genomic hybridization data.

Authors:  David Tolliver; Charalampos Tsourakakis; Ayshwarya Subramanian; Stanley Shackney; Russell Schwartz
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

3.  Modeling intra-tumor protein expression heterogeneity in tissue microarray experiments.

Authors:  Ronglai Shen; Debashis Ghosh; Jeremy M G Taylor
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373

4.  Inference of tumor phylogenies from genomic assays on heterogeneous samples.

Authors:  Ayshwarya Subramanian; Stanley Shackney; Russell Schwartz
Journal:  J Biomed Biotechnol       Date:  2012-05-13

5.  Applying unmixing to gene expression data for tumor phylogeny inference.

Authors:  Russell Schwartz; Stanley E Shackney
Journal:  BMC Bioinformatics       Date:  2010-01-20       Impact factor: 3.169

6.  Joint variable selection and classification with immunohistochemical data.

Authors:  Debashis Ghosh; Ratna Chakrabarti
Journal:  Biomark Insights       Date:  2009-07-22

7.  A simplicial complex-based approach to unmixing tumor progression data.

Authors:  Theodore Roman; Amir Nayyeri; Brittany Terese Fasy; Russell Schwartz
Journal:  BMC Bioinformatics       Date:  2015-08-12       Impact factor: 3.169

8.  Medoidshift clustering applied to genomic bulk tumor data.

Authors:  Theodore Roman; Lu Xie; Russell Schwartz
Journal:  BMC Genomics       Date:  2016-01-11       Impact factor: 3.969

9.  Automated deconvolution of structured mixtures from heterogeneous tumor genomic data.

Authors:  Theodore Roman; Lu Xie; Russell Schwartz
Journal:  PLoS Comput Biol       Date:  2017-10-23       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.